1st ESPID Summer School in Vaccinology
Athens, 16TH-20TH September 2024

The 1st ESPID Summer School aims to enrich knowledge in Vaccinology for a small select group of 30 participants, chosen among ESPID members. The scientific program developed by the ESPID Board along with a distinguished faculty of globally recognized experts in Vaccinology aims to provide a comprehensive understanding of various facets of vaccinology. The topics covered will include immunology, vaccine development, clinical trials, regulatory processes, emerging vaccines, vaccination strategies and policies, program implementation, addressing vaccine hesitancy, managing humanitarian emergencies, and exploring social, ethical, financial, and communication considerations.

Day 1 (Monday, 16 September): Understanding Immunological Responses for Vaccinologists

13:45-14:00 Welcome and Objectives of the course
Speaker: Manolis Galanakis, Vana Spoulou

14:00-14:30 History of Vaccinology
Speaker: Manolis Galanakis

14:30-15:00 Overview of Vaccinology Principles: The important role of Antigen presenting cells
Speaker: Marien De Jonge
15:00-15:30 Antigen-specific B responses and Immunological Memory
Speaker: Joanna Papadatou

15:30-16:00 Overview of Vaccinology Principles: T-cell Responses
Speaker: Milos Markovic
16:00-16:30 Student’s Interaction & Coffee Break
16:30-17:00 Mucosal Immunity and development of mucosal vaccines
Speaker: Marien de Jonge

17:00-18:30 Workshop 1 (in small groups): Different vaccine antigens and immune responses
Moderators: Vana Spoulou

Protein Subunit vaccines and particle-based vaccine formulations.
Speakers: Ilan Youngster, Eleni Vergadi

Polysaccharide and Conjugate Vaccines
Speakers: Joanna Papadatou, Vana Spoulou

Live Attenuated and Inactivated Vaccines.
Speakers: Anu Goenka, Fani Ladomenou

18:30-19:00 Non-specific effects of vaccines through trained immunity
Speaker: Anu Goenka

19:00-19:30 Closing Remarks

19:30 Welcome Reception

Day 2 (Tuesday, 17 September): Vaccine Development and Implementation

08:30-09:00 Clinical Trial: Phase I, II, III
Speaker: Ilan Youngster

09:00-09:30 Vaccine Safety: Assessing Adverse Effects
Speaker: Hanna Nohynek
09:30-10:00 Regulatory Affairs in Vaccine Development and licensure
Speaker: Marco Cavaleri (zoom)

10:00-10:30 Assessing Autoimmune adverse Events following vaccination
Speaker: Christiane Sigrid Eberhardt (zoom)

10:30-11:00 Coffee Break
11:00-12:30 Introduction of Novel Vaccines in NIPs
Speaker: Shamez Ladhani (zoom), Hanna Nohynek, David Greenberg,
Vana Papevangelou, Oana Falup-Pecurariu

Cost effectiveness-Health economics
Speaker: Kostas Athanasakis

12:30-13:00 Interaction Students-Faculty

13:00-14:30 Lunch break Interaction Students-Faculty
14:30-15:00 Post Licensure Surveillance Systems on Safety and effectiveness
Speaker: Nick Andrews (zoom)

15:00-15:30 Other topics: The journey towards polio eradication
Speaker: Ananda Bandyopadhyay (zoom)

15:30-17.30 Workshop 2: Introducing new vaccines in NIP of different settings (LMIC vs High Income countries etc.)
Facilitators: Hanna Nohynek (Varicella Zoster), David Greenberg (Bexsero and MenB), Vana Papaevangelou (RSV in Pregnant Women), Oana Falup-Pecurariu (Varicella Zoster), Andrew Pollard (Bexsero and MenB), Kostas Athanasakis (Herpes Zoster)

17:30-18:00 Interaction Students-Faculty
18:00-18:30 The future of Vaccinology
Speaker: David Greenberg

Day 3 (Wednesday, 18 September): Clinical Vaccinology Vaccines in specific populations

08:30-09:00 Vaccination in Early Life
Speaker: Eleni Vergadi
09:00-09:30 Vaccination during Pregnancy
Speaker: Flor Munoz
09:30-10:00 Vaccination for Immunocompromised Individuals
Speaker: Vana Spoulou
10:00-10:30 Travel vaccines
Speaker: Flor Munoz (Dengue, Malaria), Hanna Nohynek (Yellow Fever, Typhoid)

10:30-11:00 Coffee Break
11:00-11:30 Correlates of Immunity for prediction of vaccine efficacy
Speaker: Milos Markovic

11:30-13:30 Workshop 3: Predicting clinical effectiveness in “special populations” using correlates of protection and limitations
Facilitators: : Milos Markovic ,Eleni Vergadi, Joanna Papadatou, Vana Spoulou

13:30-15:00 Lunch break

15:00-15:30 Adverse effects of vaccination: Lessons from the pandemic
Speaker: Andrew Pollard

15:30-17:30 Workshop 4: Clinical Vaccinology: Problem Solving in special circumstances.
Facilitators: Despoina Gkentzi, Fani Ladomenou, Ioanna Pavlopoulou, Susanna Esposito, Ulrich Heininger

17:30 Historical Visit

Day 4 (Thursday, 19 September): “Novel Vaccines”

08:30-09:00 Preclinical Development and Testing including Industry Decisions to “Go or Not Go”
Speaker: Ralf Rene Reinert

09:00-09:30 mRNA vaccines for infections and beyond
Speaker: Mathew Snape

09:30–10:00 Adjuvants , Other platforms svlp, nanoparticles, etc
Speaker: Lilli Stergiou

10:00-10:30 Coffee Break
10:30-11:00 Inequalities in vaccine accessibility in LMIC
Speaker: Katherine O’Brien

11.00-12.30 An update, CMV, Strep B, TB Vaccines, RSV
Supervisors: Anu Goenka (COVID), Ulrich Heininger (pertussis), Desponia Gkenzi (CMV),
Vana Spoulou (HIV), Fani Ladomenou (STREP B), Maria Tsolia (TB)

12:30-13:00 Pertussis Vaccine: A never-ending story or may be not?
Speaker: Ulrich Heininger

13:00-14:30 Lunch break
14:30-15:00 Structure-based vaccine design for RSV and pandemic preparedness
Speaker: Barney Graham (zoom)

15:00-15:30 Influenza biology, new vaccines, and vaccination strategies for different ages
Speaker: Susanna Esposito

15:30-16:00 Introducing pandemic vaccines amidst a Global Pandemic
Speaker: David Greenberg

16:00-16:30 Debate RSV vaccine in Pregnant WOMAN vs Monoclonals in the baby
Debaters: Flor Munoz (maternal vaccination) /Vana Papaevangelou (Monoclonals to baby)

16.30-17:00 Human Challenge Studies – Are They Necessary and Ethical?
Speaker: Pierre van Damme

18.00 Quiz + Farewell dinner

Day 5 (Friday, 20 September): Vaccine implementation and Communication
08:30- 09.15 Communication Strategies for Addressing Vaccine Hesitancy focusing on your country
Speaker: Ioanna Pavlopoulou, Pierre van Damme

09:15-10:00 Engaging with the Media/Social on Vaccination
Speaker: Daniel McCormac, Samantha Vanderslott

10:00-11:30 Workshop Practice Doctor vs Parent
Facilitators: Georgios Pappas, John Kopsidas (social media), Manolis Galanakis

Workshop: Doctor Vs. Journalist
Facilitator: Samantha Vanderslott, Daniel McCormac, Hanna Nohynek – AstraZeneca case, Scandinavian Countries

11:00-11:30 Coffee Break

11:30-12:00 Debate Mandatory Immunisation in Health professionals
Debaters (Speakers): Manolis Galanakis (yes), vs Pierre Van Damme (No)

12:00-12:30 Diplomas & Conclusions

European Accreditation Council for Continuing Medical Education (UEMS/EACCME)

An application has been made to the UEMS-EACCME® for CME accreditation for this event.

American Medical Association (AMA)

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at https://www.ama-assn.org/education/ama-pra-credit-system/agreement-european-union-medical-specialties-uems

Royal College of Physicians and Surgeons of Canada

Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada. For more information, visit: https://www.royalcollege.ca/ca/en/cpd/royal-college-accredited-cpd-providers/international-accreditation-agreements.html

Educational Objectives

After participating in this educational event, learners should be able to:

• Address individual needs in compliance with their Continuous Professional Development (CPD) plan.
• Apply immunological principles
• Demonstrate advanced competence in the vaccine development process
• Make informed clinical decisions regarding vaccination in special populations
• Assess and integrate the latest knowledge of novel vaccines and emerging technologies
• Enhance communication strategies to effectively address vaccine hesitancy
• Evaluate and apply ethical principles in vaccinology
• Utilize improved problem-solving skills to address complex scenarios

Target Audience

The principal intended recipients of the 1st ESPID Summer School are fully qualified medical specialist doctors, particularly those who are members of the European Society for Paediatric Infectious Diseases (ESPID). The program is designed for participants who are at a senior level in their careers, such as experienced pediatric infectious disease specialists or those with a strong focus on vaccinology.

To Receive Your CME/CPD Certificate

The CME/CPD certificate will be available after completing the online evaluation and credit claiming procedure. The process takes about 5 minutes. We thank you for your feedback as it is an important part of CME/CPD accreditation and helps improve future educational offerings.

Kindly note that the online evaluation will be active on the last day of the meeting. You will then be able to access it and claim your CME/CPD certificate.

Disclosure and Resolution of Personal Conflicts of Interest

In accordance with CME/CPD accreditation criteria and standards for commercial support to ensure balance, independence, objectivity, and scientific rigor, those in control of the educational content must disclose potential or actual conflicts of interest. Disclosure information is evaluated and conflicts of interest are resolved. Disclosure is made to participants prior to the activity. Participants will be asked on the evaluation to assess the objectivity and independence of the event.

Industry Support Disclosure

This event is supported, in part, by funding from industry. All support is managed in strict accordance with CME/CPD accreditation criteria and standards for commercial support. Appropriate acknowledgement of all supporting organisations is made in the programme guide, on the event website, and with signage during the event.

Commitment to the Highest Standards in CME/CPD

Kenes Group is committed to being a valuable and knowledgeable partner in the design and delivery of educationally strong, independent, transparent, and effective CME/CPD programmes. Kenes is a proud member of the Good CME Practice Group (gCMEp), a member organisation contributing to improving health outcomes by:

• Championing best practice in CME/CPD
• Maintaining and improving standards
• Mentoring and educating
• Working in collaboration with critical stakeholders

 

 

Membership in the Good CME Practice Group illustrates Kenes commitment to high standards and knowledgeable partnership with its clients in the design and delivery of medical events.